Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Beacon Pharmaceutical Limited, The Bower 4 Roundwood Avenue, Stockley Park, Heathrow, United Kingdom, UB11 1AF
Volplex 4% w/v Solution for Infusion.
| Pharmaceutical Form |
|---|
|
Sterile non-pyrogenic solution for infusion. A clear pale yellow or straw coloured solution contained within a flexible infusion bag. Key Physico-chemical properties: Weight average molecular weight (Mw): 30 000 Dalton |
Succinylated gelatin (Modified Fluid Gelatin) 4% w/v in Water for Injections, also containing sodium chloride.
Electrolytes:
Sodium ion (Na+): 154 mmol/litre
Chloride ion (Cl¯): 125 mmol/litre
| Active Ingredient | Description | |
|---|---|---|
| Gelatin |
Gelatin is a colloidal plasma substitute. When used in the treatment of hypovolaemia gelatin produces significant increases in blood volume, cardiac output, stroke volume, blood pressure, urinary output and oxygen delivery. Gelatin promotes osmotic diuresis, thereby helping to protect the kidneys from the adverse effects of hypovolaemia. |
| List of Excipients |
|---|
|
Sodium chloride |
Volplex is supplied in sterile flexible infusion bags (500 or 1,000 ml), which are overwrapped.
For 500 ml bags, each pack contains 10 units.
For 1,000 ml bags, each pack contains 6 units.
Beacon Pharmaceutical Limited, The Bower 4 Roundwood Avenue, Stockley Park, Heathrow, United Kingdom, UB11 1AF
PL 18157/0243
09/06/2010
| Drug | Countries | |
|---|---|---|
| VOLPLEX | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
